Endomorphin 1 and 2, endogenous μ-opioid agonists, decrease systematic arterial pressure in the rat

Life Sciences

Volumn 62, Issue 13, 1998, Pages

  Czapla, Marc A ^a   Champion, Hunter C ^a   Zadina, James E ^a,b   Kastin, Abba J ^a,b   Hackler, Laszlo ^a,b   Ge, Lin Jun ^a,b   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Endomorphin 1; Endomorphin 2; Naloxone sensitive mechanism; Vasodepressor activity

Indexed keywords

ENDORPHIN 1; ENDORPHIN 2; ENDORPHIN DERIVATIVE; METENKEPHALIN; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; NOCICEPTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG MECHANISM; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RAT;

ANALGESICS, OPIOID; ANIMALS; BLOOD PRESSURE; ENKEPHALIN, METHIONINE; FEMALE; MALE; OLIGOPEPTIDES; OPIOID PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; VASOCONSTRICTOR AGENTS;

ANIMALIA;

EID: 4243804613     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00048-4     Document Type: Article

References (16)

1. 1. J.W. HOLADAY, Ann. Rev. Pharmacol. 23 541-594 (1983).
2. 2. M.W. JOHNSON, W.E. MITCH and C.S. WILCOX Prog. Cardiovasc. Dis. 27 435-450 (1985).
3. 3. G. FEURSTEIN and A. SIREN, Circulation 75 I125-I129 (1987).
4. 4. J.E. ZADINA, L. HACKLER and A. KASTIN, Nature 386 499-502 (1997).
5. 5. A.G.J. EVANS, P.A. NASMYTH and H.C. STEWART, Br. J. Pharmacol. 7 542-552 (1952).
6. 6. M.R. FENNESSY and J.F. RATTRAY, Eur. J. Pharmacol. 14 1-8 (1971).
7. 7. W. FELDBERG and W.D.M. PATON, J. Physiol. 144 490-509 (1951).
8. 8. W. FELDBERG and W.D.M. PATON, J. Physiol. 111 19P (1950).
9. 9. R.H. MOORE and D.A. DOWLING, Regul. Pent. 1 77-87 (1980).
10. 10. P.A. NASMYTH and H.C. STEWART, J. Physiol. 111 19P (1950).
11. 11. I. LE MAIRE, R. TSENG and S. LE MAIRE, Proc. Natl. Acad. Sci. USA 75 6240-6242 (1978).
12. 12. G.W. BISSET, H.S. CHOWDREY and W. FELDBERG, Br. J. Pharmacol. 61 370-371 (1978).
13. 13. R.C. DE BODO, J. Pharmacol. Exp. Ther. 82 74-85 (1944).
14. 14. H. SCHNIEDEN and E.K. BLACKMORE, Br. J. Pharmacol. 1 45-50 (1955).
15. 15. G.B. STEFANO, A. HARTMAN, T.V. BILFINGER, H.I. MAGAZINE, Y. LIU, F. CASARES and M.S. GOLIGORSKY, J. Biol. Chem 270 30290-30293 (1995).
16. 16. L. PARRA, F. PEREZ-VIZCAINO, A. ALSASUA, M.I. MARTIN and J. TAMARGO, Eur. J. Pharmacol. 277 99-105 (1995).